Wednesday, November 9, 2016

BRIEF-ARIAD announces phase 1/2 trial data on investigational drug Brigatinib Published in The Lancet Oncology

* ARIAD announces phase 1/2 trial data on investigational

drug Brigatinib published in the Lancet Oncology

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)